TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages
- PMID: 12101276
TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages
Abstract
We studied the interaction of transforming growth factor-beta1 (TGF-beta1) and interferon-gamma (IFN-gamma) in regulating Ag presentation in macrophages. TGF-beta1 blocked, and IFN-gamma enhanced Ag presentation of two T cell epitopes from the group A streptococcal M protein processed from viable Streptococcus pyogenes. Consistent with the functional data, TGF-beta1 reduced the constitutive expression of MHC class II transactivator (CIITA), MHC class II (MHC-II), invariant chain, and DO mRNA, whereas IFN-gamma up-regulated the expression of CIITA and MHC-II mRNA without affecting invariant chain or DO mRNA. However, neither cytokine affected DM mRNA expression. Treatment of macrophages with the two cytokines in combination showed that TGF-beta1 down-regulated IFN-gamma-mediated enhancement of antigen presentation and inhibited IFN-gamma-inducible CIITA and MHC-II class II mRNA expression. The effect of TGF-beta1 on Ag presentation was shown to be independent of the surface expression of CD80, CD86, or CD40 costimulatory molecules by flow cytometry. Our results show that TGF-beta1 and IFN-gamma cross-regulate Ag presentation by influencing the transcription of several genes associated with antigen presentation function, which may represent an important mechanism limiting T cell activation during an immune response.
Similar articles
-
TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.J Immunol. 1997 Mar 1;158(5):2065-75. J Immunol. 1997. PMID: 9036950
-
TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation.Genes Cells. 2006 Aug;11(8):871-82. doi: 10.1111/j.1365-2443.2006.00988.x. Genes Cells. 2006. PMID: 16866871
-
MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?Br J Cancer. 2000 Nov;83(9):1192-201. doi: 10.1054/bjoc.2000.1415. Br J Cancer. 2000. PMID: 11027433 Free PMC article.
-
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).Clin Ter. 2006 Jul-Aug;157(4):377-86. Clin Ter. 2006. Retraction in: Clin Ter. 2008 May-Jun;159(3):207. PMID: 17051976 Retracted. Review.
-
Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.Int Rev Immunol. 2009;28(3-4):239-60. doi: 10.1080/08830180902978120. Int Rev Immunol. 2009. PMID: 19811323 Review.
Cited by
-
Changes in Holstein cow milk and serum proteins during intramammary infection with three different strains of Staphylococcus aureus.BMC Vet Res. 2011 Sep 1;7:51. doi: 10.1186/1746-6148-7-51. BMC Vet Res. 2011. PMID: 21884610 Free PMC article.
-
Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.J Virol. 2014 Sep 1;88(17):10078-91. doi: 10.1128/JVI.01150-14. Epub 2014 Jun 25. J Virol. 2014. PMID: 24965457 Free PMC article.
-
Therapeutic targeting of TGF-β in lung cancer.FEBS J. 2025 Apr;292(7):1520-1557. doi: 10.1111/febs.17234. Epub 2024 Jul 31. FEBS J. 2025. PMID: 39083441 Free PMC article. Review.
-
The host-protective effect of arabinosylated lipoarabinomannan against Leishmania donovani infection is associated with restoration of IFN-γ responsiveness.PLoS One. 2015 Feb 6;10(2):e0117247. doi: 10.1371/journal.pone.0117247. eCollection 2015. PLoS One. 2015. PMID: 25658110 Free PMC article.
-
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β.Front Immunol. 2019 Nov 15;10:2689. doi: 10.3389/fimmu.2019.02689. eCollection 2019. Front Immunol. 2019. PMID: 31803194 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials